Skip to main content
. Author manuscript; available in PMC: 2009 Jun 23.
Published in final edited form as: Dig Dis Sci. 1998 Feb;43(2):311–316. doi: 10.1023/a:1018898120673

Table 1.

Prostaglandin Levels in Rectal Mucosal Biopsy Specimens*

Prostaglandin ng/mg protein
Baseline
change
(%)
Control FAP FAP & SUL
PGD2 1.541 ± 0.461 1.136 ± 0.182 0.729 ± 0.450c −38.8
PGE2 5.355 ± 1.015 4.832 ± 0.454 2.930 ± 1.820bc −32.3
PGF2a 3.345 ± 0.791 2.917 ± 0.881 1.618 ± 0.888bc −43.6
TXB2 0.945 ± 0.042 1.673 ± 0.329a 1.005 ± 0.643b −45.2
6KPGF1a 0.960 ± 0.482 1.184 ± 0.108 0.567 ± 0.307bc −49.5
*

Results are mean ± SD. FAP is familial adenomatous polyposis; FAP & SUL is FAP patients treated with sulindac.

a

P = 0.016 FAP compared to control

b

P = 0.05 FAP compared with FAP treated with sulindac

c

P = 0.05 FAP treated with sulindac compared to control.

Percent change from baseline in patients before and after sulindac treatment.